Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 3/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | MMP13 | P45452 | 1/20 | 0.40 |
| ▸ | MYC | P01106 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3648818 | 0.80 | ALOX15 (0.44) | ALDH1A1ALOX15MAPTHDAC8F2 | |
| SCHEMBL1449566 | 0.77 | ALDH1A1 (0.52) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| SCHEMBL6372852 | 0.77 | ALDH1A1 (0.56) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| Hydrochloric Acid SCHEMBL6093184 | 0.76 | ALDH1A1 (0.50) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| Hydrazine SCHEMBL27571459 | 0.75 | ALDH1A1 (0.54) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| SCHEMBL254364 | 0.74 | ALDH1A1 (0.59) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| Hydrogen Peroxide SCHEMBL9514730 | 0.74 | ALDH1A1 (0.59) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| SCHEMBL134091 | 0.74 | ALDH1A1 (0.59) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| SCHEMBL29657201 | 0.74 | ALDH1A1 (0.59) | ALDH1A1ALOX15GAAKMT2ATDP1 | |
| Benzene SCHEMBL28132022 | 0.74 | ALDH1A1 (0.59) | ALDH1A1ALOX15GAAKMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230136215-A1 | PRODUCTION OF DUNALIELLA | UNIVERSITY OF GREENWICH (GB) | 2023-05-04 | — | — | US | disclosed |
| US-20200368302-A1 | PRODUCTION OF DUNALIELLA | UNIVERSITY OF GREENWICH (GB) | 2020-11-26 | — | — | US | disclosed |
| EP-2928869-A1 | 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | Chiesi Farmaceutici S.p.A. (IT) | 2015-10-14 | — | — | EP | disclosed |
| WO-2014086865-A1 | 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2014-06-12 | — | — | WO | disclosed |
| EP-2421533-A1 | NOVEL ANTI-INFLAMMATORY AGENTS | RESVERLOGIX CORP. (CA) | 2012-02-29 | — | — | EP | disclosed |
| WO-2010123975-A1 | NOVEL ANTI-INFLAMMATORY AGENTS | RESVERLOGIX CORP. (CA) | 2010-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230136215-A1 | PRODUCTION OF DUNALIELLA | DDT, DLD, DAGLA | ALDH1A1 2223/4885ALOX15 1214/4885GAA 1167/4885 |
| US-20200368302-A1 | PRODUCTION OF DUNALIELLA | DDT, DLD, DAGLA | ALDH1A1 2223/4885ALOX15 1214/4885GAA 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.